ClinicalTrials.Veeva

Menu

Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure (Deltalus)

U

University of Monastir

Status

Enrolling

Conditions

Emergencies
Acute Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT05871138
Delta- LUS

Details and patient eligibility

About

prognostic value of delta LUS score of patients hospitalized for acute heart failure within 30 days of discharge.

Full description

The aim of our study is to evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac decompensation 30 days after discharge.

Delta LUS score=((LUS2-LUS1) *100)/LUS1

Enrollment

500 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged over 18 years,
  • Patients hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit).

Exclusion criteria

  • Age less than 18 years
  • Dyspnea of non-cardiac etiology (cause: pulmonary, traumatic, toxic...)
  • Altered state of consciousness (Glasgow score<14)
  • Hemodynamic instability: presence of peripheral signs of shock, use of vasoactive drugs
  • Mechanical ventilation from the outset
  • Cardiorespiratory arrest
  • Inability to give consent to the study
  • Missing one of two ultrasound examinations
  • Unable to make telephone contact after one month.

Trial contacts and locations

2

Loading...

Central trial contact

Nouira Semir, Pr; Bel Hadj Ali Khaoula, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems